Neil Bodick, COO of Chorus - Eli Lilly and Co to Give Plenary Keynote Address at 3rd Modern Drug Discovery and Development Summit

Released on: October 11, 2007, 3:13 pm

Press Release Author: GTCbio

Industry: Pharmaceuticals

Press Release Summary: COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote
Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).

Press Release Body: MONROVIA, CA - Neil Bodick, Chief Operating Officer, Chorus,
Lilly Research Laboratories at
Eli Lilly and Company is one of four plenary keynote presenters at GTCbio's 3rd
Modern Drug Discovery and Development Summit (M3D) on November 28-30, 2007 at the
Hyatt Regency San Francisco Airport.

At M3D, Bodick will discuss one of Eli Lilly's business units, Chorus, and its
experience in early phase drug development. Chorus, a part of Lilly Research
Laboratories, develops new chemical entities from candidate selection to clinical
Proof of Concept (PoC), conducting minimal amount of work to demonstrate clinical
viability and deferring scale-up of operations until completion of PoC.

The unit relies on external networks of experts and service providers, and work is
coordinated through proprietary software systems. Bodick's presentation will review
the numerous positive and negative PoCs that have been achieved in the first three
years of operation as well as productivity gains relative to industry standard.

The 3rd Modern Drug Discovery & Development Summit features over 150 speakers
participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference
workshops. Tracks include Biological Therapeutics, Drug Delivery Technology,
Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and
Pharmaco - Kinetics, Dynamics, Genomics and Genetics. For more information, visit
www.gtcbio.com.


ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com



Web Site: http://www.gtcbio.com

Contact Details: GTCbio
434 W Foothill Blvd.
Monrovia, CA 92880
Ph:626) 256-6405
Fax: 626) 256-6460

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •